These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 19097588

  • 1. Current proteomic analysis and post-translational modifications of biomarkers in human lung cancer materials.
    Sinchaikul S, Hongsachart P, Sriyam S, Tantipaiboonwong P, Phutrakul S, Chen ST.
    Chang Gung Med J; 2008; 31(5):417-30. PubMed ID: 19097588
    [Abstract] [Full Text] [Related]

  • 2. Proteomics analysis in lung cancer: challenges and opportunities.
    Kikuchi T, Carbone DP.
    Respirology; 2007 Jan; 12(1):22-8. PubMed ID: 17207021
    [Abstract] [Full Text] [Related]

  • 3. Sub-speciating Campylobacter jejuni by proteomic analysis of its protein biomarkers and their post-translational modifications.
    Fagerquist CK, Bates AH, Heath S, King BC, Garbus BR, Harden LA, Miller WG.
    J Proteome Res; 2006 Oct; 5(10):2527-38. PubMed ID: 17022624
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A, Ma PC, Salgia R.
    Mass Spectrom Rev; 2007 Oct; 26(3):451-66. PubMed ID: 17407130
    [Abstract] [Full Text] [Related]

  • 7. Clinical cancer proteomics: promises and pitfalls.
    Alaiya A, Al-Mohanna M, Linder S.
    J Proteome Res; 2005 Oct; 4(4):1213-22. PubMed ID: 16083271
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Present status of clinical proteomic analysis for the early detection and determination of therapeutic strategy in lung cancer.
    Hirano T, Kato H.
    Ann Thorac Cardiovasc Surg; 2006 Feb; 12(1):4-9. PubMed ID: 16572067
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical proteomics: discovery of cancer biomarkers using mass spectrometry and bioinformatics approaches--a prostate cancer perspective.
    Matharoo-Ball B, Ball G, Rees R.
    Vaccine; 2007 Sep 27; 25 Suppl 2():B110-21. PubMed ID: 17916461
    [Abstract] [Full Text] [Related]

  • 13. Proteomic analysis of bone cancer: a review of current and future developments.
    Bhattacharyya S, Byrum S, Siegel ER, Suva LJ.
    Expert Rev Proteomics; 2007 Jun 27; 4(3):371-8. PubMed ID: 17552921
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.
    Hongsachart P, Huang-Liu R, Sinchaikul S, Pan FM, Phutrakul S, Chuang YM, Yu CJ, Chen ST.
    Electrophoresis; 2009 Apr 27; 30(7):1206-20. PubMed ID: 19294700
    [Abstract] [Full Text] [Related]

  • 16. Strategies for plasma proteomic profiling of cancers.
    Omenn GS.
    Proteomics; 2006 Oct 27; 6(20):5662-73. PubMed ID: 16991194
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.